{"retracted":false,"update":{"timestamp":1393891200000,"doi":"10.1007/s00415-014-7280-4","type":"correction"},"doi":"10.1007/s00415-013-7115-8","journal":"Journal of Neurology","publisher":"Springer Nature","title":"Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study"}
